Paper39375526
An international survey to better understand the current incidence, severity, and management of VOD/SOS.
Larue M and 22 others. Bone Marrow Transplant, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. An international survey to better understand the current incidence, severity, and management of VOD/SOS. Papers, record 39375526. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39375526
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An international survey to better understand the current incidence, severity, and management of VOD/SOS.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatic Veno-Occlusive Disease | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Humans | |
| Incidence | |
| Surveys and Questionnaires | |
| Male | |
| Female | |
| Severity of Illness Index | |
| Adult | |
| Middle Aged |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27183098 | Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. | Bone Marrow Transplant | 2016 | https://conductscience.org/library/papers/27183098 | PubMed |
| 2 | 28759025 | Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. | Bone Marrow Transplant | 2018 | https://conductscience.org/library/papers/28759025 | PubMed |
| 3 | 38287083 | Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease. | Bone Marrow Transplant | 2024 | https://conductscience.org/library/papers/38287083 | PubMed |
| 4 | 38266155 | Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation. | Blood Adv | 2024 | https://conductscience.org/library/papers/38266155 | PubMed |
| 5 | 35594010 | A Systematic Review and Meta-Analysis of Studies of Defibrotide Prophylaxis for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. | Clin Drug Investig | 2022 | https://conductscience.org/library/papers/35594010 | PubMed |
| 6 | 24102514 | BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. | Br J Haematol | 2013 | https://conductscience.org/library/papers/24102514 | PubMed |
| 7 | 26825712 | Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. | Blood | 2016 | https://conductscience.org/library/papers/26825712 | PubMed |
| 8 | 8355040 | Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. | J Clin Oncol | 1993 | https://conductscience.org/library/papers/8355040 | PubMed |
| 9 | 34666352 | Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant. | Blood Adv | 2022 | https://conductscience.org/library/papers/34666352 | PubMed |
| 10 | 30797942 | Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30797942 | PubMed |
| 11 | 32318059 | Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation. | Front Immunol | 2020 | https://conductscience.org/library/papers/32318059 | PubMed |
| 12 | 3321587 | Venoocclusive disease of the liver following bone marrow transplantation. | Transplantation | 1987 | https://conductscience.org/library/papers/3321587 | PubMed |
| 13 | 37095231 | Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT). | Bone Marrow Transplant | 2023 | https://conductscience.org/library/papers/37095231 | PubMed |
| 14 | 27992075 | Management of veno-occlusive disease: the multidisciplinary approach to care. | Eur J Haematol | 2017 | https://conductscience.org/library/papers/27992075 | PubMed |
| 15 | 32133623 | Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation. | Br J Haematol | 2020 | https://conductscience.org/library/papers/32133623 | PubMed |
| 16 | 36765638 | Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36765638 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42469395 | Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC). | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42469395 | PubMed |
| 41530538 | Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT). | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/41530538 | PubMed |
| 40263636 | Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group. | Bone Marrow Transplant | 2025 | https://conductscience.org/library/papers/40263636 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39375526
GET https://conductscience.org/api/papers/v1/39375526/authors?page=2